Some immunologically cold tumors like prostate and pancreatic cancers show very low expression of CD40 in their microenvironment (10) and foreseeably, very rarely respond to the checkpoint inhibitors (9, 10, 34, 35). This evidence concerns the gene CD40 and familial pancreatic carcinoma.